 NextCure Inc NASDAQ:NXTC gapped down prior to trading on Tuesday after BTIG Research lowered their price target on the stock from 61.00 to 27.00. The stock had previously closed at 3.55, but opened at 8.15. BTIG Research currently has a buy rating on the stock. NextCure shares last traded at 8.94, with a volume of ... 